ArticleBMC cancer2016

Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.

Mariko Noguchi-Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.